Once again the opinions expressed below are my opinion and should not be construed as investment advice
Malmanu I noticed you have a sentinent of none and a disclosure of not held
Let me be more explicit about your question as to whether Acorn are selling it's holdings in Starpharma rather than giving you a definite no
Below is part on an analysis that I conducted on Acorn in an earlier post on another thread
Acorn sold 1,303,833 shares in Starpharma for $1,011,479.94 at an average price of 77.5 cents from 15th of May 2014 until 3rd of October 2014. From this I am assuming when share price spiked to 98 cents recently Acorn decided to take a profit.
FACT - ACORN STILL HOLDS 8 PER CENT OF STARPHARMA SHARES
FACT - ACORN DID NOT TAKE UP ANY NEW SHARES IN THE RECENT SHARE PLACEMENT CAUSING DILUTION OF IT'S HOLDINGS
FACT - IF STARPHARMA HAD NOT INCREASED IT'S SHARE BASE ACTUAL PERCENTAGE SOLD BY ACORN WOULD HAVE BEEN ONLY 0.45 % OF HOLDINGS.
The reality is Acorn would have needed to sell
3,947,370 in shares based on an 8 per cent current holding and it did not. In fact only
1,302,600 shares were sold - and because Acorn did not take up any new shares -
it was diluted
I thought to add something to this post that explains high frequency trading
